Cell Impact AB
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company offers production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was inc… Read more
Cell Impact AB (CI) - Net Assets
Latest net assets as of September 2025: Skr187.48 Million SEK
Based on the latest financial reports, Cell Impact AB (CI) has net assets worth Skr187.48 Million SEK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr216.69 Million) and total liabilities (Skr29.21 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr187.48 Million |
| % of Total Assets | 86.52% |
| Annual Growth Rate | 48.89% |
| 5-Year Change | 8.52% |
| 10-Year Change | 9263.88% |
| Growth Volatility | 445.55 |
Cell Impact AB - Net Assets Trend (2008–2024)
This chart illustrates how Cell Impact AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cell Impact AB (2008–2024)
The table below shows the annual net assets of Cell Impact AB from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr219.08 Million | -27.78% |
| 2023-12-31 | Skr303.37 Million | -6.47% |
| 2022-12-31 | Skr324.35 Million | +127.41% |
| 2021-12-31 | Skr142.62 Million | -29.35% |
| 2020-12-31 | Skr201.89 Million | +348.11% |
| 2019-12-31 | Skr45.05 Million | +135.41% |
| 2018-12-31 | Skr19.14 Million | -17.11% |
| 2017-12-31 | Skr23.09 Million | -44.20% |
| 2016-12-31 | Skr41.38 Million | +1668.66% |
| 2015-12-31 | Skr2.34 Million | -71.54% |
| 2014-12-31 | Skr8.22 Million | -48.88% |
| 2013-12-31 | Skr16.08 Million | +855.61% |
| 2012-12-31 | Skr1.68 Million | -13.11% |
| 2011-12-31 | Skr1.94 Million | +409.74% |
| 2010-12-31 | Skr380.00K | +1.25% |
| 2009-12-31 | Skr375.31K | -0.03% |
| 2008-12-31 | Skr375.44K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cell Impact AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 59623944000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr80.60 Million | 36.79% |
| Other Components | Skr734.73 Million | 335.37% |
| Total Equity | Skr219.08 Million | 100.00% |
Cell Impact AB Competitors by Market Cap
The table below lists competitors of Cell Impact AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Polaris Investama Tbk
JK:PLAS
|
$3.26 Million |
|
SAMSUNG EPISHOLDINGS CO LTD
KO:0126Z0
|
$3.26 Million |
|
Kubera Gold Corp.
V:KBRA
|
$3.26 Million |
|
Neith Corporation
TWO:6236
|
$3.26 Million |
|
CADOGAN ENERGY SOLUTIONS
F:CPD
|
$3.25 Million |
|
FUXING CHINA GRP SD 5
F:3FU1
|
$3.25 Million |
|
SAMYUNG ENC Co. Ltd
KQ:065570
|
$3.25 Million |
|
KWESST Micro Systems Inc. Common Stock
NASDAQ:KWE
|
$3.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cell Impact AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 303,369,000 to 219,081,000, a change of -84,288,000 (-27.8%).
- Net loss of 100,433,000 reduced equity.
- New share issuances of 17,821,000 increased equity.
- Other comprehensive income increased equity by 39,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-100.43 Million | -45.84% |
| Share Issuances | Skr17.82 Million | +8.13% |
| Other Comprehensive Income | Skr39.00K | +0.02% |
| Other Changes | Skr-1.72 Million | -0.78% |
| Total Change | Skr- | -27.78% |
Book Value vs Market Value Analysis
This analysis compares Cell Impact AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.36x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.02x to 0.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | Skr0.04 | Skr0.13 | x |
| 2009-12-31 | Skr0.04 | Skr0.13 | x |
| 2010-12-31 | Skr0.04 | Skr0.13 | x |
| 2011-12-31 | Skr0.22 | Skr0.13 | x |
| 2012-12-31 | Skr0.05 | Skr0.13 | x |
| 2013-12-31 | Skr1.88 | Skr0.13 | x |
| 2014-12-31 | Skr0.52 | Skr0.13 | x |
| 2015-12-31 | Skr0.27 | Skr0.13 | x |
| 2016-12-31 | Skr0.87 | Skr0.13 | x |
| 2017-12-31 | Skr0.33 | Skr0.13 | x |
| 2018-12-31 | Skr0.79 | Skr0.13 | x |
| 2019-12-31 | Skr1.26 | Skr0.13 | x |
| 2020-12-31 | Skr4.01 | Skr0.13 | x |
| 2021-12-31 | Skr0.76 | Skr0.13 | x |
| 2022-12-31 | Skr1.36 | Skr0.13 | x |
| 2023-12-31 | Skr2.77 | Skr0.13 | x |
| 2024-12-31 | Skr0.35 | Skr0.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cell Impact AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -45.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -269.08%
- • Asset Turnover: 0.14x
- • Equity Multiplier: 1.19x
- Recent ROE (-45.84%) is above the historical average (-144.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 1.22% | 0.00% | 0.00x | 1.04x | Skr-32.95K |
| 2009 | -0.03% | 0.00% | 0.00x | 1.01x | Skr-37.66K |
| 2010 | -109.96% | -1612.21% | 0.00x | 42.91x | Skr-455.84K |
| 2011 | -770.57% | -834.79% | 0.23x | 4.08x | Skr-15.12 Million |
| 2012 | -482.38% | -605.90% | 0.25x | 3.17x | Skr-8.29 Million |
| 2013 | -47.24% | -228.79% | 0.17x | 1.20x | Skr-9.21 Million |
| 2014 | -94.25% | -219.33% | 0.31x | 1.37x | Skr-8.57 Million |
| 2015 | -315.52% | -397.31% | 0.24x | 3.28x | Skr-7.62 Million |
| 2016 | -20.74% | -470.10% | 0.03x | 1.27x | Skr-12.72 Million |
| 2017 | -79.23% | -1190.89% | 0.05x | 1.28x | Skr-20.60 Million |
| 2018 | -232.90% | -679.04% | 0.17x | 1.99x | Skr-46.49 Million |
| 2019 | -107.43% | -406.08% | 0.21x | 1.29x | Skr-52.91 Million |
| 2020 | -21.92% | -151.00% | 0.12x | 1.20x | Skr-64.45 Million |
| 2021 | -55.99% | -111.92% | 0.30x | 1.67x | Skr-94.12 Million |
| 2022 | -32.13% | -135.68% | 0.19x | 1.24x | Skr-136.65 Million |
| 2023 | -40.02% | -256.88% | 0.12x | 1.26x | Skr-151.74 Million |
| 2024 | -45.84% | -269.08% | 0.14x | 1.19x | Skr-122.34 Million |
Industry Comparison
This section compares Cell Impact AB's net assets metrics with peer companies in the Metal Fabrication industry.
Industry Context
- Industry: Metal Fabrication
- Average net assets among peers: $253,701,167
- Average return on equity (ROE) among peers: 11.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cell Impact AB (CI) | Skr187.48 Million | 1.22% | 0.16x | $3.25 Million |
| AGES Industri AB (publ) (AGES-B) | $402.48 Million | 13.88% | 1.18x | $5.03 Million |
| HAKI Safety A (HAKI-A) | $684.00 Million | 4.97% | 1.09x | $19.52 Million |
| Nordic Flanges Group AB (NFGAB) | $40.27 Million | -30.33% | 1.79x | $483.40K |
| Precomp Solutions AB Series B (PCOM-B) | $27.69 Million | 34.85% | 2.71x | $1.17 Million |
| ProfilGruppen AB (publ) (PROF-B) | $324.60 Million | 22.49% | 1.29x | $17.39 Million |
| Troax Group AB (TROAX) | $43.16 Million | 20.17% | 2.16x | $335.22 Million |